Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
S. Andrea Hospital
With
Italian Multiple Sclerosis Foundation
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients affected by remitting Multiple Sclerosis who had at least a relapse in the last year of the disease.
Satisfying general clinical conditions according to the researcher. Adequate hepatic function. Capacity to use adequate contraceptive techniques during the study.
You may not be if
Any other disease that might better explain signs and symptoms of the patient.
Any other disability condition that might interfere with the clinical evolution.
History of hypersensitivity to natural or recombinant interferon or to human albumin.
Clinically significant heart diseases and not controlled like dysrhythmias, angina pectoris or congestive heart failure.
Not adequately controlled epilepsy.
Inability, according to the examining commission, to grant a complete compliance with the protocol requirements for the whole study.
Previous therapies modifying the disease course in the last six months.
Steroid therapies in the last 3 months.
Pregnancy, lactation, serological positivity to the pregnancy test during the screening period.
Clareo Health | Interferon ß-1b Treatment by Cyclical Administration
